Rehabilitation of Individuals With Cancer
- PMID: 35508925
- PMCID: PMC9081390
- DOI: 10.5535/arm.22036
Rehabilitation of Individuals With Cancer
Abstract
The survival rate of cancer is increasing as treatment improves. As patients with cancer now live longer, impairments may arise that impact quality of life (QOL) and function. Therefore, a focus on QOL is often as important as survival. An interdisciplinary team can achieve goal-oriented and patient-centered rehabilitation, which can optimize function and QOL, and minimize impairments, restrictions, and activity limitations. In most cases, cancer patients must be active participants in therapy and exhibit carryover. Patients with cancer often have impairments that include fatigue, pain, brain fog, impaired cognition, paresis, mood disorders, difficulty with activities of daily living (ADL), bowel/bladder/sexual dysfunction, and bone and soft tissue involvement. Adaptive equipment, exercise, and ADL training can mitigate restrictions on activity. The trajectory and phase of the disease along the continuum of cancer care may influence the goals of rehabilitation in that time window. QOL is often influenced by participation in vocational, recreational, and home-based activities. A holistic perspective should include an analysis of distress, socioeconomic barriers, and transportation limitations when addressing issues.
Keywords: Cancer; Exercise programs; Lymphedema; Rehababilitation.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
References
-
- National Cancer Institute NCI dictionary of cancer terms [Internet] Washington, DC: National Cancer Institute. c2022 [cited 2022 Apr 15]. Available from: http://www.cancer.gov/dictionary.
-
- World Health Organization . International classification of functioning, disability and health. Geneva, Switzerland: World Health Organization; 2001. pp. 1–25.
-
- Santucci C, Carioli G, Bertuccio P, Malvezzi M, Pastorino U, Boffetta P, et al. Progress in cancer mortality, incidence, and survival: a global overview. Eur J Cancer Prev. 2020;29:367–81. - PubMed
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
